Edition:
United States

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Capital Market

1.45USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
101,710
52-wk High
$98.00
52-wk Low
$1.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.05 -2.083
Jun '17 0.07 -4.127
Mar '17 0.11 -11.657
FY 2016 Dec '16 0.16 -4.582
Sep '16 0.15 -11.830
Jun '16 0.49 -9.672
Mar '16 0.15 -11.342
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.05 0.05 0.05 --
Quarter Ending Jun-18 1 0.05 0.05 0.05 --
Year Ending Dec-18 1 0.20 0.20 0.20 52.01
Earnings (per share)
Quarter Ending Mar-18 1 -1.80 -1.80 -1.80 --
Quarter Ending Jun-18 1 -1.80 -1.80 -1.80 --
Year Ending Dec-18 1 -7.00 -7.00 -7.00 -23.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.03 34.43
P/E High - Last 5 Yrs. -- 41.47 46.75
P/E Low - Last 5 Yrs. -- 23.35 24.14
Beta 1.21 0.81 0.81
Price to Sales (TTM) 16.25 6.26 8.57
Price to Book (MRQ) -- 4.27 5.14
Price to Tangible Book (MRQ) -- 4.76 6.30
Price to Cash Flow (TTM) -- 22.77 25.75
% Owned Institutions 6.65 1.27 2.33

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.26 5.27
Payout Ratio(TTM) -- 45.36 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -63.55 8.53 9.45
Sales (TTM) vs TTM 1 Yr. Ago -54.18 6.35 7.30
Sales - 5 Yr. Growth Rate -34.16 9.90 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.39 16.64 20.15
EPS (TTM) vs TTM 1 Yr. Ago 54.83 -- --
EPS - 5 Yr. Growth Rate -- 10.39 11.48
Capital Spending - 5 Yr. Growth Rate 128.88 14.63 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.38 2.42
Current Ratio (MRQ) 2.29 3.33 3.38
LT Debt to Equity (MRQ) -- 8.98 11.85
Total Debt to Equity (MRQ) -- 12.06 15.12
Interest Coverage (TTM) -31.70 44.83 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.25 54.90
Gross Margin - 5 Yr. Avg. -- 52.61 52.64
EBITD Margin (TTM) -10,420.15 -- --
EBITD - 5 Yr. Avg -1,435.49 18.52 9.86
Operating Margin (TTM) -18,889.80 11.43 1.25
Operating Margin - 5 Yr. Avg. -1,462.72 14.30 5.07
Pre-Tax Margin (TTM) -13,782.42 11.82 2.12
Pre-Tax Margin - 5 Yr. Avg. -1,446.56 14.58 5.33
Net Profit Margin (TTM) -13,782.42 8.21 -1.38
Net Profit Margin - 5 Yr. Avg. -1,446.56 10.92 1.62
Effective Tax Rate (TTM) -- 22.39 22.03
Effective Tax Rate - 5 Yr. Avg. -- 23.57 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,214 919,747,049 819,569,446
Net Income/Employee (TTM) -442,947 107,578,762 95,804,981
Receivable Turnover (TTM) 5.40 5.29 5.40
Inventory Turnover (TTM) -- 2.59 3.48
Asset Turnover (TTM) 0.01 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -80.35 11.11 10.68
Return on Assets - 5 Yr. Avg. -100.93 12.64 12.00
Return on Investment (TTM) -107.01 14.00 13.54
Return on Investment - 5 Yr. Avg. -133.29 16.55 15.72
Return on Equity (TTM) -3,419.65 15.34 14.80
Return on Equity - 5 Yr. Avg. -- 17.61 16.91
  1 Year 3 Year 5 Year
Sales % 82.41 -40.20 -34.16
EPS (TTM) % 54.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Argos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.65%
# of Holders: 33
Total Shares Held: 292,364
3 Mo. Net Change: -3,280
# New Positions: 4
# Closed Positions: 7
# Increased Positions: 11
# Reduced Positions: 13
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.